Cardiac MRI of patients with implanted electrical cardiac devices

Heart

Volumn 100, Issue 5, 2014, Pages 363-369

  Ainslie, Mark ^a   Miller, Christopher ^a   Brown, Benjamin ^a   Schmitt, Matthias ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERROMAGNETIC MATERIAL;

ARTIFACT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEVICE RECALL; DEVICE SAFETY; ELECTROMAGNETIC RADIATION; EQUIPMENT DESIGN; FORCE; HEART PACING; HEART RHYTHM; HUMAN; IMAGE QUALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE PULSE GENERATOR; MAGNETIC FIELD; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION ENERGY; RADIATION HAZARD; RADIOFREQUENCY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TORQUE; TREATMENT CONTRAINDICATION;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; PACEMAKER, ARTIFICIAL; PRACTICE GUIDELINES AS TOPIC;

EID: 84896721493     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304324     Document Type: Review

References (46)

1. Sutton R, Kanal E, Wilkoff BL, et al. Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI Surescan pacing system: clinical study design. Trials 2008;9:68.
2. Bruder O, Wagner A, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry-multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson 2013;15:9.
3. Antony R, Daghem M, McCann GP, et al. Cardiovascular magnetic resonance activity in the United Kingdom: a survey on behalf of the British Society of Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson 2011;13:57.
4. Cunningham D, Whittaker T. Cardiac Rhythm Management UK National Clinical Audit Report, 2011.
5. Kalin R, Stanton MS. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. PACE 2005;28:2878-91.
6. Gimbel JR, Bailey SM, Tchou PJ, et al. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005;28:1041-6. (Pubitemid 43951406)
7. Gimbel JR. Unexpected asystole during T magnetic resonance imaging of a pacemaker-dependent patient with a "modern" pacemaker. Europace 2009;11:1241-2
8. Luechinger R, Schwitter J. Safety in MRI. In: Schwitter J. CMR update. 2008:28-41.
9. Pohost GM, Blackwell GG, Shellock FG. Safety of patients with medical devices during application of magnetic resonance methods. Ann N Y Acad Sci 1992;649:302-12.
10. Gimbel JR, Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol 2004;43:1325-7. (Pubitemid 38452613)
11. Shellock FG, Crues JV. MR Safety and the American College of Radiology White Paper. Am J Roentgenol 2002;178:1349-52. (Pubitemid 34547811)
12. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part II. Pacing Clin Electrophysiol 2002;25:1496-509. (Pubitemid 35222808)
13. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart 2001;86:246-8. (Pubitemid 32800066)
14. Erlebacher JA, Cahill PT, Pannizzo F, et al. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol 1986;57:437-40. (Pubitemid 16119716)
15. Hayes DL, Vlietstra RE. Pacemaker malfunction. Ann Intern Med 1993;119:828-35. (Pubitemid 24012649)
16. Pavlicek W, Geisinger M, Castle L, et al. The effects of nuclear magnetic resonance on patients with cardiac pacemakers. Radiology 1983;147:149-53. (Pubitemid 13112334)
17. Fetter J, Aram G, Holmes DR Jr, et al. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol 1984;7:720-7. (Pubitemid 14037689)
18. Nazarian S, Halperin HR. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm 2009;6:138-43.
19. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004;110:475-82. (Pubitemid 39031161)
20. Tandri H, Zviman MM, Wedan SR, et al. Determinants of gradient field-induced current in a pacemaker lead system in a magnetic resonance imaging environment. Heart Rhythm 2008;5:462-8.
21. Achenbach S, Moshage W, Diem B, et al. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997;134:467-73. (Pubitemid 27431252)
22. Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73.
23. Bottomley PA, Redington RW, Edelstein W a, et al. Estimating radiofrequency power deposition in body NMR imaging. Magn Reson Med 1985;2:336-49. (Pubitemid 15228815)
24. Chou CK, Bassen H, Osepchuk J, et al. Radio frequency electromagnetic exposure: tutorial review on experimental dosimetry. Bioelectromagnetics 1996;17:195-208. (Pubitemid 126469702)
25. Cline H, Mallozzi R, Li Z, et al. Radiofrequency power deposition utilizing thermal imaging. Mag Reson Med 2004;51:1129-37. (Pubitemid 38796997)
26. Bottomley PA, Edelstein WA. Power deposition in whole body NMR imaging. Med Phys 1981;8:510-2. (Pubitemid 11122527)
27. Luechinger R, Zeijlemaker VA, Pedersen EM, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005;26:376-83; discussion 325-7. (Pubitemid 40283097)
28. Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285-92. (Pubitemid 44402054)
29. Shellock FG, Tkach JA, Ruggieri PM, et al. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5-and 3.0-Tesla MR systems. J Cardiovas Magn Reson 2003;5:387-97. (Pubitemid 36569957)
30. Levine GN, Gomes AS, Arai AE, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007;116:2878-91. (Pubitemid 350291228)
31. Luechinger R, Duru F, Zeijlemaker VA, et al. Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002;25:1419-23. (Pubitemid 35222797)
32. Lauck G, Von Smekal A, Wolke S, et al. Effects of nuclear magnetic resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol 1995;18:1549-55.
33. Mollerus M, Albin G, Lipinski M, et al. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 2009;32:772-8.
34. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-24. (Pubitemid 38452612)
35. Roguin A, Schwitter J, Vahlhaus C, et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008;10:336-46. (Pubitemid 351773738)
36. Irnich W, Irnich B, Bartsch C, et al. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005;7:353-65. (Pubitemid 40790421)
37. Bovenschulte H, Schlüter-Brust K, Liebig T, et al. MRI in patients with pacemakers: overview and procedural management. Dtsch Ärztebl Int 2012;109:270-5.
38. Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance. Ann Intern Med 2011;155:415-24.
39. Junttila MJ, Fishman JE, Lopera G a, et al. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart 2011;97:1852-6.
40. Russo RJ. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry. Am Heart J 2013;165:266-72.
41. Russo RJ, Costa HS, Doud D, et al. Determining the risks of magnetic resonance imaging at 1.5 Tesla for patients with pacemakers and implantable cardioverter defibrillators (The Magnasafe Registry). Am Heart Assoc Sci Sessions 2012;126: A11726.
42. Rod Gimbel J, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm2013:10:685-91.
43. Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators/clinical perspective. Circ Cardiovasc Imaging 2011;4:662-70.
44. Schwitter J, Kanal E, Schmitt M, et al. Impact of the Advisa MRITM Pacing System on the diagnostic quality of cardiac MR images and contraction patterns of cardiac muscle during scans: Advisa MRI randomized clinical multicenter study results. Heart Rhythm 2013;10:864-72.
45. Jones M, Rajappan K. Implantable devices and cardiac MRI scans-no longer an absolute contraindication. Cardiol News 2011;14:14-17.
46. Schmitt M, Busca R, Davidson NC. Risk of needing an MRI in pacemaker patients based on analysis of English hospital statistics. ESMRMB Congress 2009;22:491-2.